Calcium Phosphate As a Key Material for Socially Responsible Tissue Engineering

Calcium Phosphate As a Key Material for Socially Responsible Tissue Engineering

materials Review Calcium Phosphate as a Key Material for Socially Responsible Tissue Engineering Vuk Uskokovi´c 1,2,* and Victoria M. Wu 1 1 Department of Bioengineering, University of Illinois, Chicago, IL 60607-7052, USA; [email protected] 2 Department of Biomedical and Pharmaceutical Sciences, Chapman University, Irvine, CA 92618-1908, USA * Correspondence: [email protected] or [email protected]; Tel.: +1-415-412-0233 Academic Editor: Carlos Lodeiro Received: 15 March 2016; Accepted: 27 May 2016; Published: 1 June 2016 Abstract: Socially responsible technologies are designed while taking into consideration the socioeconomic, geopolitical and environmental limitations of regions in which they will be implemented. In the medical context, this involves making therapeutic platforms more accessible and affordable to patients in poor regions of the world wherein a given disease is endemic. This often necessitates going against the reigning trend of making therapeutic nanoparticles ever more structurally complex and expensive. However, studies aimed at simplifying materials and formulations while maintaining the functionality and therapeutic response of their more complex counterparts seldom provoke a significant interest in the scientific community. In this review we demonstrate that such compositional simplifications are meaningful when it comes to the design of a solution for osteomyelitis, a disease that is in its natural, non-postoperative form particularly prevalent in the underdeveloped parts of the world wherein poverty, poor sanitary conditions, and chronically compromised defense lines of the immune system are the norm. We show that calcium phosphate nanoparticles, which are inexpensive to make, could be chemically designed to possess the same functionality as a hypothetic mixture additionally composed of: (a) a bone growth factor; (b) an antibiotic for prophylactic or anti-infective purposes; (c) a bisphosphonate as an antiresorptive compound; (d) a viral vector to enable the intracellular delivery of therapeutics; (e) a luminescent dye; (f) a radiographic component; (g) an imaging contrast agent; (h) a magnetic domain; and (i) polymers as viscous components enabling the injectability of the material and acting as carriers for the sustained release of a drug. In particular, calcium phosphates could: (a) produce tunable drug release profiles; (b) take the form of viscous and injectable, self-setting pastes; (c) be naturally osteo-inductive and inhibitory for osteoclastogenesis; (d) intracellularly deliver bioactive compounds; (e) accommodate an array of functional ions; (f) be processed into macroporous constructs for tissue engineering; and (g) be naturally antimicrobial. All in all, we see in calcium phosphates the presence of a protean nature whose therapeutic potentials have been barely tapped into. Keywords: antimicrobials; biomaterials; biomedicine; calcium phosphate; drug delivery; hydroxyapatite; nanomaterials; nanotechnology; social responsibility; sustainability 1. Introduction “I have to leave the convent and consecrate myself to the poor” [1]. Mother Teresa, Calcutta—Darjeeling train, 1946. Socially responsible design of nanomaterials, including therapeutic nanostructures, is rarely addressed. Only one publication listed in Elsevier’s bibliographic database Scopus contains both the terms “socially responsible” and “nano” [2]. Socially responsible design is tied to the aim of acting for Materials 2016, 9, 434; doi:10.3390/ma9060434 www.mdpi.com/journal/materials Materials 2016, 9, 434 2 of 27 the benefit of society at large and oftentimes involves making the product affordable to impoverished populationsMaterials through 2016, 9, 434structural and compositional simplification. This approach, however,2 of 26 clashes with the common assumption that the more structurally and functionally complex the nanoparticle, for the benefit of society at large and oftentimes involves making the product affordable to the greaterimpoverished its applicative populations potentials. through For structural this reason, and compositional structural and simplification. functional This complexification approach, of nanoparticleshowever, elicits clashes a greaterwith the interestcommon fromassumption the scientific that the more community structurally than and their functionally simplification. complex Quite often, however,the nanoparticle, an extensive the greater cost isits associated applicative withpotentials. synthesis For this and reason, characterization structural and (necessary functional to verify the structurecomplexification and the correct of nanoparticles composition) elicits of a suchgreater complex interest nanostructures.from the scientific As community such, their than consideration their simplification. Quite often, however, an extensive cost is associated with synthesis and for a prompt therapeutic application in poor regions of the world and underprivileged communities is characterization (necessary to verify the structure and the correct composition) of such complex equivocal,nanostructures. if not illusory. As such, their consideration for a prompt therapeutic application in poor regions of Onethe example world and comes underprivileged from osteomyelitis, communities the is equivocal, diseasethat if not is illusory. prevalent in poor sanitary conditions typical for underdevelopedOne example comes regions from osteomyelitis, of the world the [disease3]. Although that is prevalent an interest in poor for sanitary finding conditions more advanced and patient-friendlytypical for underdeveloped solutions to regions it has recentlyof the world emerged [3]. Although because an interest the disease for finding is often more secondary advanced to bone surgeriesand [4 ,patient-friendly5], the frequency solutions of which to it followshas recently in step emerged with because the continuously the disease is aging often averagesecondary population to bone surgeries [4,5], the frequency of which follows in step with the continuously aging average of the developed world, in its natural form it is predominantly present in environments where low population of the developed world, in its natural form it is predominantly present in environments hygiene,where malnutrition, low hygiene, other malnutrition, infectious other diseases, infectious compromised diseases, compromised immunity immunity and povertyand poverty are are endemic. Figure1a,endemic. for example, Figure 1a, illustrates for example, the illustrates disparity the between disparity the between percentage the percentage of hospitalizations of hospitalizations due to bone infectiondue in to the bone US andinfection in Africa: in the 1%–2%US and vs.in Africa:7%–20%, 1%–2% respectively. vs. 7%–20%, In respectively. this non-postoperative In this non- form, the diseasepostoperative is, moreover, form, particularlythe disease is, knownmoreover, for partic strikingularly childrenknown for [6 striking]. Ideally, children therefore, [6]. Ideally, the therapy for osteomyelitistherefore, the should therapy be for affordable osteomyelitis to the should inhabitants be affordable of poorer to the inhabitant regions ofs of the poorer world regions than of those in the world than those in which the most advanced tissue engineering solutions for bone disease are which thebeing most developed advanced today. tissue engineering solutions for bone disease are being developed today. Figure 1. (a) Percentage of hospitalizations due to osteomyelitis, equaling 1.23% in the United States Figure 1.and(a ranging) Percentage from 7% of to hospitalizations 20% in Africa. The duearea tobelow osteomyelitis, and above 7% equaling differs in color—yellow 1.23% in the and United red, States and rangingrespectively. from 7%Data to retrieved 20% in Africa.from Refs. The [7–9]; area (b below) Percentage and above of mineral, 7% differs organic, in color—yellowand aqueous and red, respectively.components Dataof three retrieved major hard from tissues Refs. in the [7 human–9]; (b body,) Percentage demonstrating of mineral, calcium organic,phosphate and(CAP) aqueous componentsas the ofmost three abundant major component hard tissues of each in the of humanthe three body, of them: demonstrating bone, dentin and calcium enamel. phosphate Adapted (CAP) as the mostfrom abundant[10] with permission component from of©2008 each Mineralogical of the three Society of them: of America. bone, dentin and enamel. Adapted from [10] with permission from ©2008 Mineralogical Society of America. Typical therapies for osteomyelitis include oral or parenteral administrations of antibiotics ranging in duration from 2–6 weeks depending on the severity of infection as well as surgical Typicaldebridement therapies of the for osteomyelitisinfected and necrotic include tissue oral [1 or1,12]. parenteral This rather administrations invasive therapy of antibioticssuffers from ranging in duration from 2–6 weeks depending on the severity of infection as well as surgical debridement of the infected and necrotic tissue [11,12]. This rather invasive therapy suffers from numerous drawbacks, including (a) the side effects tied with systemic distribution of antibiotics; (b) their Materials 2016, 9, 434 3 of 27 low bioavailability due to impaired vascularization of an already lowly vascularized boney tissues; (c) skeletal disfigurement resulting from the surgical intervention; and (d) the risk of new infection accompanying open surgery [13]. Therefore, attempted to be developed are therapies involving the minimally invasive injection

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    27 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us